Linda W. Martin

Biomarker Integration in the Perioperative Management of Early-Stage Non-Small-Cell Lung Cancer

The concept of personalized medicine has tremendous appeal—tailoring diagnosis and treatment to an individual, rather than a “one-size-fits-all” approach. The management of non-small-cell lung cancer (NSCLC) has rapidly evolved toward strategies increasingly guided by tumor biology and precision oncology. The safety an...